Prevent roadblocks during development.
This week's Fierce Biotech is brought to you by Thermo Fisher Scientific. Trouble viewing? Click here. |
When developing the chemical process of an active pharmaceutical ingredient (API), oftentimes little consideration is given to the final drug product formulation. The result of this siloed approach, however, can mean the yield of an API that is difficult to handle or requires additional processing before manufacturing the final formulation. Download this white paper to learn more about how certain physical API properties can impact drug product formulation and how creating an integrated approach may prevent roadblocks during development. | |
Thermo Fisher Scientific, 4815 Emperor Blvd., Durham, NC 27703-8470, USA +1 866-728-4366 | +1 919-226-3200 | Contact Us | Privacy Policy | |
|
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy. Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017 |
|